Search

Seven students will be awarded PhD degrees on May 19, 2021, from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK), an innovative doctoral program that prepares the next generation of basic laboratory scientists to work in research areas related to human disease with a focus on cancer.

… Monday, May 17, 2021 Seven students will be awarded PhD degrees on May 19, 2021, from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) , an innovative doctoral program that prepares the next generation of basic laboratory scientists to work in research areas related to human

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Tuesday, April 30, 2024 Victoria Blinder Awarded Funding from the Patient-Centered Outcomes Research Institute Victoria Blinder, MD, FASCO Victoria Blinder, MD, FASCO , medical oncologist, was  awarded funding from the Patient-Centered Outcomes Research Institute (PCORI) on behalf of the Alliance NCTN

Read an interview with Sloan Kettering Institute Computational and Systems Biology Chair Dana Pe'er.

… Friday, January 1, 2021 Dana Pe’er is Chair of the Computational and Systems Biology Program at the Sloan Kettering Institute (SKI). She came to Memorial Sloan Kettering Cancer Center in 2016, with the goal of bringing her mathematical and computational expertise to bear on the problem of cancer. An

Get to know Ana Silveira, a computational biology postdoctoral fellow in the Sloan Kettering Institute.

… Thursday, March 26, 2020 Summary As part of Women’s History Month, we are profiling some of MSK’s star female graduate students and postdoctoral fellows training to be leaders in their fields. Ana Silveira is a postdoctoral fellow in the Chodera lab  in the Sloan Kettering Institute. When you look back

Learn about how MSK’s new Lobular Breast Cancer Program is working to improve outcomes for people with invasive lobular breast cancer and other types of LBC.

… Thursday, October 2, 2025 Because lobular breast cancer (LBC) is a type of breast cancer that can be difficult to detect and challenging to treat, it is the focus of a special program at Memorial Sloan Kettering Cancer Center (MSK). Also called invasive lobular carcinoma, it is the second most common

Radiation is a feasible option for patients with squamous cell carcinoma of the anterior nasal cavity mucosa who refuse rhinectomy, according to our recent research.

… Friday, June 7, 2019 Our findings demonstrate that a non-operative approach with high-dose radiotherapy and concurrent chemoradiotherapy can result in favorable outcomes. Marc A. Cohen Associate Chief Medical Officer, Access and Patient Flow; Surgical Director, Pituitary and Skull Base Tumor Center Radiation

Hear from cervical cancer survivor Susan Shaw about how she joined the Empire Dragon Boat Team three years ago and is in the best shape of her life.

… Tuesday, August 21, 2018 Summary This story originally appeared in Bridges, MSK’s newsletter for cancer survivors. Bridges offers a forum in which patients and their families can share stories of inspiration and hope, and of the challenges that can accompany a cancer journey. Learn more about how to

Our recent prospective study data provides support for the incorporation of plasma next-generation sequencing (NGS) assays into lung cancer practice guidelines.

… Friday, February 8, 2019 Among patients who tested plasma NGS positive for oncogenic driver alterations recognized by the National Comprehensive Cancer Network guidelines (EGFR, KRAS, ALK, ROS1, RET, BRAF, MET, HER2), 96.1 percent were concordant on tissue NGS. Bob T. Li Vice President, Global Research

我们最近的前瞻性研究数据为将血浆下一代测序 (NGS) 检测纳入肺癌实践指南提供了支持。

… Friday, February 8, 2019 经国家综合癌症网络指南（EGFR、KRAS、ALK、ROS1、RET、BRAF、MET、HER2）认可的血浆 NGS 检测致癌驱动突变阳性中，组织 NGS 符合率高达 96.1%。 Bob T. Li Vice President, Global Research Affairs; Physician Ambassador to China and Asia-Pacific, Bobst International Center; Co-Director, Thoracic Liquid Biopsy Program 我们最近的前瞻性研究数据为血浆下一代测序

Researchers at Memorial Sloan Kettering (MSK) report that firefighters at the World Trade Center (WTC) scene in September 2001 were nearly twice as likely as the general population to have a multiple myeloma precursor condition called monoclonal gammopathy of undetermined significance (MGUS). This new research was published online today in JAMA Oncology.

… Thursday, April 26, 2018 Researchers at Memorial Sloan Kettering (MSK) report that firefighters at the World Trade Center (WTC) scene in September 2001 were nearly twice as likely as the general population to have a multiple myeloma precursor condition called monoclonal gammopathy of undetermined significance